Andelyn Biosciences – Teeing Off for One Big Purpose

Andelyn Biosciences is a leading and patient-focused cell and gene therapy Contract Development and Manufacturing Organization (CDMO) in Columbus, Ohio. Their line of business may sound complicated; however, their vision is quite simple – Turning Hope Into Reality™ for patients and families affected by rare and ultra-rare diseases where no treatment currently exists. There are over 10,000 rare diseases worldwide, 70% of which begin in childhood with many resulting in fatal outcomes. It is Andelyn’s mission, together with their partners, to accelerate the development and manufacturing of innovative therapies to bring more treatments to more patients affected by such devasting diagnoses.
While Andelyn stands ready and capable to provide Hope to those in need, the reality is there are many challenges that face the rare disease community before they can get to the point of treatment. Many experience delays in diagnosis, encounter limited or no treatment options, and face barriers to financial resources. Programs working toward developing life-altering therapies tend to rely on public, private, or non-profit funding to assist with their critical research and development work. This is primarily because populations in the rare disease community are too small to be a financially viable investment for commercial development pathways, often resulting in significant program delays due to financial limitations.

“Seeing programs delayed due to financial constraints is incredibly difficult to witness, especially when you know a patient, someone’s son or daughter, is waiting for a treatment, is waiting for hope,” said Wade Macedone, Chief Executive Officer of Andelyn. “In knowing this, along with the immense promise that gene therapies offer, we are taking it personally to create a platform to help raise awareness and funds to support the rare disease community we serve.” The platform that Andelyn references is a golf outing titled Fore One Purpose. The inaugural outing will take place on Monday, September 30th at The Country Club at Muirfield Village in Dublin, Ohio.

Andelyn intends to make a meaningful impact in their charitable giving debut, with Wade stating, “Fore One Purpose is an incredible opportunity to give sponsors, golfers, and Central Ohio a means to help – a means to help and learn about a community they may, fortunately, be unfamiliar with. Our goal is to shine a light on patient stories and programs that are in critical need, as well as some that have seen success. This is imperative to show the life-altering and life-saving potential that gene therapies provide.” Wade continues, “Our purpose behind this outing is to raise awareness to help give life to the science behind treatments and, in turn, use that science to give life. We know there is a lot of work to be done in this space but if we can help just one patient and one family to start, we will have done our job. One purpose, one treatment, one life – that is our goal.”

Fore One Purpose promises to benefit the rare disease community in Central Ohio and beyond, helping to expose the profound need behind these vital treatments and providing education and awareness opportunities along the way. Andelyn will embed a human element into their charity golf event by hosting patient ambassadors, providing a tangible experience for their guests to connect diseases with patients and the purpose behind teeing off for such a worthy and determined cause. The proceeds raised from the outing will be given to a non-profit foundation of Andelyn’s choice in critical need.

If you are interested in learning more about Andelyn’s charity golf event, please visit https://fore-one-purpose.com/. Sponsorship opportunities are available, along with in-kind monetary and silent auction donations. Should you have questions on how to donate or get involved, Andelyn encourages you to email giving@andelynbiosciences.com.

About Andelyn Biosciences, Inc.
Andelyn Biosciences is a full-service cell and gene therapy CDMO (Contract Development and Manufacturing Organization) focused on the development, characterization and production of viral vectors for gene therapy. With more than 20 years of experience, Andelyn’s deep scientific expertise has resulted in the production of cGMP material for more than 450 clinical batches and 75 global clinical trials. Operating out of three Columbus, Ohio facilities, Andelyn supports its clients in developing cell and gene therapies from concept through plasmid engineering and manufacturing, process and analytical development, and cGMP clinical and commercial manufacturing. Andelyn can accelerate programs and deliver high-quality products by developing and manufacturing processes on its configurable, data-driven AAV Curator™ Platform, or tech transfer an established client program. Capabilities include cGMP manufacturing for both adherent and suspension processes up to a 2,000-liter capacity. Vertically integrated rigorous quality systems, regulatory support, and supply chain further support clients in bringing their critical therapies to market. For more information, visit andelynbio.com.